Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics

Hepatology Oct 11, 2018

Nardelli S, et al. - Researchers investigated whether there was an association between minimal hepatic encephalopathy (MHE) and proton pump inhibitors (PPIs) use as well as the role of PPIs use in the development of overt HE and survival via including 310 consecutive cirrhotic patients and followed up for 14.1±12.3 months. PPIs use, previous overt HE, low albumin, low sodium and age were the variables independently related to the presence of MHE. PPIs, history of overt HE, low albumin, MHE and age were variables independently related to the development of overt HE. On the other hand, PPIs, development of overt HE, MELD score, age, low sodium and age were variables independently associated with mortality. In patients with liver cirrhosis, they identified a potentially removable factor associated with the presence of minimal HE and related to the development of overt HE and survival.
Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay